Dashboard
Manage Tickers

PEPGPepGen Inc.

Nasdaq pepgen.com


$ 9.88 $ 0.21 (2.17 %)    

Monday, 26-Aug-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 474.46 $ -5.47 (-1.14 %)
DIA $ 412.48 $ 0.89 (0.22 %)
SPY $ 560.78 $ -1.35 (-0.24 %)
TLT $ 98.13 $ -0.26 (-0.26 %)
GLD $ 232.75 $ 0.74 (0.32 %)
$ 9.88
$ 9.73
$ 9.82 x 200
-- x --
$ 9.51 - $ 10.05
$ 3.72 - $ 19.30
82,715
na
321.99M
$ 0.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-23-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 06-16-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pepgen-q2-eps-087-misses-072-estimate
PepGen Q2 EPS $(0.87) Misses $(0.72) Estimate
08/08/2024 12:29:55

PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.72) by 2...

hc-wainwright--co-reiterates-buy-on-pepgen-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on PepG...
08/01/2024 10:37:59

HC Wainwright & Co. analyst Andrew Fein reiterates PepGen (NASDAQ:PEPG) with a Buy and maintains $26 price target.

nasdaq-surges-over-3-powell-industries-shares-spike-higher
Nasdaq Surges Over 3%; Powell Industries S...
07/31/2024 19:02:17

dow-jumps-over-200-points-kraft-heinz-shares-gain-after-q2-earnings
Dow Jumps Over 200 Points; Kraft Heinz Sha...
07/31/2024 16:45:07

wedbush-reiterates-outperform-on-pepgen-maintains-20-price-target
Wedbush Reiterates Outperform on PepGen, M...
07/31/2024 16:00:25

Wedbush analyst Laura Chico reiterates PepGen (NASDAQ:PEPG) with a Outperform and maintains $20 price target.

pepgen-shares-data-from-low-dose-cohort-of-pgn-edo51-in-ongoing-connect1-edo51-phase-2-clinical-trial-for-treatment-of-duchenne-muscular-dystrophy-says-was-well-tolerated-and-all-patients-continued-to-long-term-extension-portion-of-trial-dosing-of-second-cohort-at-10-mgkg-is-ongoing
PepGen Shares Data From Low-Dose Cohort Of...
07/30/2024 20:26:55

– PGN-EDO51 at 5 mg/kg was well tolerated, and all patients continued to long-term extension portion of trial. Dosing of second...

pepgen-files-250m-mixed-securities-shelf
PepGen Files $250M Mixed Securities Shelf
06/28/2024 20:08:37

hc-wainwright--co-reiterates-buy-on-pepgen-maintains-26-price-target
HC Wainwright & Co. Reiterates Buy on PepG...
05/15/2024 15:16:58

HC Wainwright & Co. analyst Andrew Fein reiterates PepGen (NASDAQ:PEPG) with a Buy and maintains $26 price target.

wedbush-reiterates-outperform-on-pepgen-maintains-20-price-target
Wedbush Reiterates Outperform on PepGen, M...
05/15/2024 13:45:25

Wedbush analyst Laura Chico reiterates PepGen (NASDAQ:PEPG) with a Outperform and maintains $20 price target.

correction-pepgen-q1-2024-gaap-eps-063-beats-074-estimate
CORRECTION: PepGen Q1 2024 GAAP EPS $(0.63...
05/14/2024 20:36:01

PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.74) by 14....

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/12/2024 12:09:54

insiders-buying-gamestop-and-2-other-stocks
Insiders Buying GameStop And 2 Other Stocks
04/10/2024 12:11:19

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

pepgen-receives-us-fda-orphan-drug-and-rare-pediatric-disease-designations-for-pgn-edo51-for-the-treatment-of-duchenne-muscular-dystrophy
PepGen Receives U.S. FDA Orphan Drug And R...
03/13/2024 11:01:33

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/07/2024 17:31:22

pepgen-reported-march-6-q4-2023-gaap-eps-0810-beats-1010-estimate
PepGen Reported March 6 Q4 2023 GAAP EPS $...
03/07/2024 15:55:58

PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.810) per share which beat the analyst consensus estimate of $(1.010) by 1...

wedbush-maintains-outperform-on-pepgen-lowers-price-target-to-20
Wedbush Maintains Outperform on PepGen, Lo...
03/07/2024 13:14:09

Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and lowers the price target from $21 to $20.

pepgen-announces-clearance-of-cta-by-uk-medicines--healthcare-products-regulatory-agency-to-begin-connect2-edo51-a-phase-2-clinical-trial-designed-to-support-potential-accelerated-approval-of-pgn-edo51-for-the-treatment-of-duchenne-muscular-dystrophy
PepGen Announces Clearance of CTA by UK Me...
03/04/2024 12:04:59

PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies wi...

pepgen-receives-fda-fast-track-designation-for-pgn-edodm1-for-myotonic-dystrophy-type-1
PepGen Receives FDA Fast Track Designation...
02/20/2024 13:03:26

over-37m-bet-on-this-industrial-stock-check-out-these-4-stocks-insiders-are-buying
Over $37M Bet On This Industrial Stock? Ch...
02/14/2024 13:28:21

Although U.S. stocks closed sharply lower on Tuesday, there were a few notable insider trades.

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
02/07/2024 17:31:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION